As Covid-19 continues to devastate the global economy, DBS Research analyst Yeo Kee Yan and his team have placed their hopes for economic recovery on the successful development of a viable vaccine. With 38 candidates now undergoing clinical evaluations, one or more positive outcomes will be the spark that will fuel ailing economies, they write in a report dated Oct 6.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply